High-risk neuroblastoma
Clinical trials for High-risk neuroblastoma explained in plain language.
Never miss a new study
Get alerted when new High-risk neuroblastoma trials appear
Sign up with your email to follow new studies for High-risk neuroblastoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine aims to train immune system to attack childhood cancer
Disease control CompletedThis trial tests a vaccine designed to help the immune system recognize and attack neuroblastoma, a type of childhood cancer. The vaccine contains two antigens found on neuroblastoma cells, plus an adjuvant to boost the immune response. Participants also take an oral supplement c…
Matched conditions: HIGH-RISK NEUROBLASTOMA
Phase 1/2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New antibody combo shows promise in tough childhood cancer
Disease control CompletedThis phase 3 trial tested the safety of giving a monoclonal antibody (dinutuximab) along with immune-boosting drugs and a vitamin-like drug to children with high-risk neuroblastoma after a stem cell transplant. The goal was to see if this combination could be given safely and hel…
Matched conditions: HIGH-RISK NEUROBLASTOMA
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New immunotherapy combo shows promise for tough childhood cancer
Disease control CompletedThis study tested whether adding two immunotherapy drugs (dinutuximab and GM-CSF) to standard chemotherapy is safe and doable for children newly diagnosed with high-risk neuroblastoma. Forty-two children took part. The goal was to see if the extra drugs cause too many side effect…
Matched conditions: HIGH-RISK NEUROBLASTOMA
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC